The next generation of therapeutics for chronic kidney disease
The next generation of therapeutics for chronic kidney disease
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Approximately 20 million people in the United States are currently affected by CKD, with half a million of these presenting with the most severe form: end-stage renal disease (ESRD). The only treatments for ESRD are dialysis or transplantation. The yearly mortality of patients on dialysis can be as high as 20%, and transplantation is...
Alternative Titles
Full title
The next generation of therapeutics for chronic kidney disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5511522
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5511522
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd.2016.67
